Pitchkit
  • Docs
  • Pricing
  • Blog
  • Tools
  • Investors
Sign inGet started
Pitchkit

Structure and stress-test your pitch with workflows built from 6+ years of VC dealflow.

Product

  • Overview
  • Pitch deck feedback
  • Pitch deck generator
  • Templates
  • Pricing

Resources

  • Learn
  • Pitch by stage
  • Slide guides
  • Docs
  • Glossary
  • Free tools

Company

  • About
  • Blog
  • Changelog
  • Contact
  • Privacy policy

Ready to pitch?

Start building your investor-ready pitch today. Free forever, no credit card required.

Start free

© 2026 Pitchkit / edgelord.tech

All systems operational
Pitchkit
Back to investor directory
Venture capital
Czech Republic

ZAKA VC

Investment focus

Sectors

Enterprise
SaaS
AI
Biotech
Healthtech

Investment stages

Pre-seed
Seed

Geographic focus

Europe
Czech Republic
Central Europe

Investment thesis

A Prague-based micro-VC with 55+ portfolio companies that bridges CEE founders with US and Western European markets, writing €250K-€300K at pre-seed and seed. ZAKA acts primarily as a co-investor, making them a complementary addition to any seed round. Best for founders with CEE roots who want a connector between Central European technical talent and Western go-to-market opportunities.

Typical check size

€250k – €300k

Fund size: €15M Fund I; 55+ portfolio companies

Browse similar check sizes →

Portfolio highlights

ExcepGen - gene therapy technology company
Miros.ai - ocean wave measurement using camera technology
Supliful - white-label supplement platform

Contact

zaka.vc
Czech Republic

Research with AI

Learn more about ZAKA VC using AI:

Ask ChatGPTAsk Perplexity

Pitch guides

Learn what ZAKA VC and similar investors look for:

Enterprise pitch guideSaaS pitch guideAI pitch guide

More investors in Czech Republic

Credo VenturesPresto VenturesRockaway VenturesY Soft VenturesView all in Czech Republic

Related resources

Pre-seed fundraising guidePre-seed pitch deck guideSeed fundraising guideSeed pitch deck guideSaaS pitch deck by modelGlossary: Term sheet

More Enterprise investors

20VC2123VC468 CapitalView all Enterprise investors